These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 28789823)

  • 21. Allo-specific immune response profiles indicative of acute rejection in kidney allografts using an in vitro lymphocyte culture-based model.
    Mahakur S; Saikia B; Minz M; Minz RW; Nada R; Anand S; Sharma A; Jha V; Joshi N; Goel L; Arora A; Joshi K
    Clin Exp Nephrol; 2018 Apr; 22(2):465-473. PubMed ID: 28849286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of cardiac allograft rejection and response to immunosuppressive therapy with peripheral blood gene expression.
    Horwitz PA; Tsai EJ; Putt ME; Gilmore JM; Lepore JJ; Parmacek MS; Kao AC; Desai SS; Goldberg LR; Brozena SC; Jessup ML; Epstein JA; Cappola TP
    Circulation; 2004 Dec; 110(25):3815-21. PubMed ID: 15583081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA signatures in cardiac biopsies and detection of allograft rejection.
    Di Francesco A; Fedrigo M; Santovito D; Natarelli L; Castellani C; De Pascale F; Toscano G; Fraiese A; Feltrin G; Benazzi E; Nocco A; Thiene G; Valente M; Valle G; Schober A; Gerosa G; Angelini A
    J Heart Lung Transplant; 2018 Nov; 37(11):1329-1340. PubMed ID: 30174164
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cell-Free DNA to Detect Heart Allograft Acute Rejection.
    Agbor-Enoh S; Shah P; Tunc I; Hsu S; Russell S; Feller E; Shah K; Rodrigo ME; Najjar SS; Kong H; Pirooznia M; Fideli U; Bikineyeva A; Marishta A; Bhatti K; Yang Y; Mutebi C; Yu K; Kyoo Jang M; Marboe C; Berry GJ; Valantine HA;
    Circulation; 2021 Mar; 143(12):1184-1197. PubMed ID: 33435695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel biomarkers useful in surveillance of graft rejection after heart transplantation.
    Palmieri V; Mansueto G; Coscioni E; Maiello C; Benincasa G; Napoli C
    Transpl Immunol; 2021 Aug; 67():101406. PubMed ID: 33975013
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peripheral blood transcriptome sequencing reveals rejection-relevant genes in long-term heart transplantation.
    Chen Y; Zhang H; Xiao X; Jia Y; Wu W; Liu L; Jiang J; Zhu B; Meng X; Chen W
    Int J Cardiol; 2013 Oct; 168(3):2726-33. PubMed ID: 23602870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphorylated S6 kinase and S6 ribosomal protein are diagnostic markers of antibody-mediated rejection in heart allografts.
    Li F; Wei J; Valenzuela NM; Lai C; Zhang Q; Gjertson D; Fishbein MC; Kobashigawa JA; Deng M; Reed EF
    J Heart Lung Transplant; 2015 Apr; 34(4):580-587. PubMed ID: 25511749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of CXCL9 and CXCL10 as circulating biomarkers of human cardiac allograft rejection.
    Karason K; Jernås M; Hägg DA; Svensson PA
    BMC Cardiovasc Disord; 2006 Jun; 6():29. PubMed ID: 16780603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endomyocardial biopsy for monitoring heart transplant patients: 11-years-experience at a german heart center.
    Strecker T; Rösch J; Weyand M; Agaimy A
    Int J Clin Exp Pathol; 2013; 6(1):55-65. PubMed ID: 23236543
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloperoxidase as serum marker for detection of CMV infections and rejections in patients after liver or heart transplantation.
    Zelzer S; Stiegler P; Kapitan M; Schaffellner S; Schweiger M; Stettin M; Stojakovic T; Truschnig-Wilders M; Tscheliessnigg KH; Khoschsorur G
    Transpl Immunol; 2009 Jan; 20(3):121-6. PubMed ID: 18930821
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An ectopically expressed serum miRNA signature is prognostic, diagnostic, and biologically related to liver allograft rejection.
    Shaked A; Chang BL; Barnes MR; Sayre P; Li YR; Asare S; DesMarais M; Holmes MV; Guettouche T; Keating BJ
    Hepatology; 2017 Jan; 65(1):269-280. PubMed ID: 27533743
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictive role of pretransplant serum CXCL10 for cardiac acute rejection.
    Crescioli C; Buonamano A; Scolletta S; Sottili M; Francalanci M; Giomarelli P; Biagioli B; Lisi G; Pradella F; Serio M; Romagnani P; Maccherini M
    Transplantation; 2009 Jan; 87(2):249-55. PubMed ID: 19155980
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated serum concentrations of cardiac troponin T in acute allograft rejection after human heart transplantation.
    Dengler TJ; Zimmermann R; Braun K; Müller-Bardorff M; Zehelein J; Sack FU; Schnabel PA; Kübler W; Katus HA
    J Am Coll Cardiol; 1998 Aug; 32(2):405-12. PubMed ID: 9708468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exosome-derived galectin-9 may be a novel predictor of rejection and prognosis after liver transplantation.
    Zhang AB; Peng YF; Jia JJ; Nie Y; Zhang SY; Xie HY; Zhou L; Zheng SS
    J Zhejiang Univ Sci B; 2019 Jul; 20(7):605-612. PubMed ID: 31168974
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Outcome of antibody-mediated rejection compared to acute cellular rejection after pediatric heart transplantation.
    Vaughn GR; Jorgensen NW; Law YM; Albers EL; Hong BJ; Friedland-Little JM; Kemna MS
    Pediatr Transplant; 2018 Feb; 22(1):. PubMed ID: 29222866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SERCA2a: A potential non-invasive biomarker of cardiac allograft rejection.
    Tarazón E; Ortega A; Gil-Cayuela C; Sánchez-Lacuesta E; Marín P; Lago F; González-Juanatey JR; Martínez-Dolz L; Portolés M; Rivera M; Roselló-Lletí E
    J Heart Lung Transplant; 2017 Dec; 36(12):1322-1328. PubMed ID: 28750934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tissue-specific exosome biomarkers for noninvasively monitoring immunologic rejection of transplanted tissue.
    Vallabhajosyula P; Korutla L; Habertheuer A; Yu M; Rostami S; Yuan CX; Reddy S; Liu C; Korutla V; Koeberlein B; Trofe-Clark J; Rickels MR; Naji A
    J Clin Invest; 2017 Apr; 127(4):1375-1391. PubMed ID: 28319051
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gene Expression Profiling for the Identification and Classification of Antibody-Mediated Heart Rejection.
    Loupy A; Duong Van Huyen JP; Hidalgo L; Reeve J; Racapé M; Aubert O; Venner JM; Falmuski K; Bories MC; Beuscart T; Guillemain R; François A; Pattier S; Toquet C; Gay A; Rouvier P; Varnous S; Leprince P; Empana JP; Lefaucheur C; Bruneval P; Jouven X; Halloran PF
    Circulation; 2017 Mar; 135(10):917-935. PubMed ID: 28148598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Elevated ST2 levels are associated with antibody-mediated rejection in heart transplant recipients.
    Grupper A; AbouEzzeddine OF; Maleszewski JJ; Grupper A; Geske JR; Kremers WK; Kushwaha SS; Pereira NL
    Clin Transplant; 2018 Sep; 32(9):e13349. PubMed ID: 29998506
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Serum MiR-142-3p and MiR-101-3p Levels with Acute Cellular Rejection after Heart Transplantation.
    Sukma Dewi I; Hollander Z; Lam KK; McManus JW; Tebbutt SJ; Ng RT; Keown PA; McMaster RW; McManus BM; Gidlöf O; Öhman J
    PLoS One; 2017; 12(1):e0170842. PubMed ID: 28125729
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.